Coronary Stents Market Summary
As per MRFR Analysis, the Coronary Stents Market was valued at 6.62 USD Billion in 2024 and is projected to grow to 9.2 USD Billion by 2035, with a CAGR of 3.04% from 2025 to 2035. The market is driven by the rising prevalence of cardiovascular diseases, technological advancements in stent design, and an aging population. Drug-eluting stents are leading the market due to their effectiveness in reducing restenosis rates, while the demand for minimally invasive procedures is increasing.
Key Market Trends & Highlights
The Global Coronary Stents Market is witnessing significant growth driven by various factors.
- Market Size in 2024: 6.62 USD Billion; expected to reach 9.2 USD Billion by 2035.
- Drug-Eluting Stents segment valued at 2.88 USD Billion in 2024; projected to grow to 4.0 USD Billion by 2035.
- North America leads the market with a valuation of 2.45 USD Billion in 2024; expected to increase to 3.15 USD Billion by 2035.
- Aging population projected to reach 2.1 billion aged 60+ by 2050, correlating with increased cardiovascular issues.
Market Size & Forecast
2023 Market Size: USD 6.43 Billion
2024 Market Size: USD 6.62 Billion
2035 Market Size: USD 9.2 Billion
CAGR (2025-2035): 3.04%
Largest Regional Market Share in 2024: North America.
Major Players
Key players include MicroPort, Philips, Johnson and Johnson, Terumo, B.Braun, Abbott, Boston Scientific, and Medtronic.
The Coronary Stents Market CAGR (growth rate) is expected to be around 3.04% during the forecast period (2025 - 2035).
Key Coronary Stents Market Trends Highlighted
The Coronary Stents Market is experiencing significant trends driven by advancements in technology and a growing emphasis on patient-centered care. One of the key market drivers is the increasing prevalence of cardiovascular diseases globally.
Governments worldwide acknowledge this public health crisis and are investing in healthcare infrastructures, promoting preventive measures, and supporting innovative treatments. This focus on improving healthcare outcomes stimulates demand for high-quality coronary stents, which are crucial in addressing heart-related issues.
There are substantial opportunities to be explored in the emerging markets, where increasing healthcare access is coupled with rising disposable incomes. As awareness regarding heart diseases grows, more patients are seeking treatment options, thus fostering greater acceptance of coronary stents.
Additionally, the shift towards minimally invasive procedures is encouraging manufacturers to innovate and improve stent designs for better patient outcomes. Trends in recent times show an increasing adoption of drug-eluting stents over bare-metal stents due to their lower rates of in-stent restenosis.
Health authorities are also focusing on regulatory approvals for new stent technologies that enhance biocompatibility and reduce complications. Furthermore, the rise of telemedicine and remote patient monitoring is transforming how patient care is delivered, creating additional avenues for stent manufacturers to reach patients effectively.
As the market evolves, the integration of technological advances in stent design is expected to enhance performance and patient satisfaction across various regions.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Coronary Stents Market Drivers
Rising Prevalence of Cardiovascular Diseases
The Coronary Stents Market Industry is majorly driven by the rising prevalence of cardiovascular illnesses, which are the leading cause of death worldwide. The World Health Organization estimates that 17.9 million people died from cardiovascular illnesses in 2019, accounting for 32% of all global fatalities.
This worrying trend emphasizes the critical need for appropriate treatment alternatives such as coronary stents, which are essential in treating clogged arteries. Major organizations such as the American Heart Association and the European Society of Cardiology are actively promoting awareness and offering educational materials,
resulting in a greater focus on novel cardiovascular health solutions. The rising number of patients suffering from coronary artery disease is likely to drive up demand for stents, cementing the Coronary Stents Market Industry's growth trajectory.
Technological Advancements in Stent Design
Technological innovation within the stent manufacturing domain is empowering the growth of the Coronary Stents Market Industry. The introduction of bioresorbable stents and advanced drug-eluting stents has been pivotal in improving patient outcomes.
Research from medical device manufacturing databases shows that over 3000 patents related to stent technology were filed globally in the past five years alone, reflecting the competitive landscape and continuous Research and Development activities in the industry.
Leading corporations such as Boston Scientific and Abbott Laboratories are advancing stent designs, incorporating materials that enhance biocompatibility and reduce restenosis rates, thereby driving market growth significantly.
Government Initiatives to Promote Heart Health
Governmental bodies and health organizations worldwide are launching initiatives aimed at promoting heart health and reducing the burden of cardiovascular diseases. For instance, initiatives like the 'Healthy People 2030' program in the United States aim to improve cardiovascular health and are forecasted to significantly increase screening and treatment rates among at-risk populations.
The U.S. Centers for Disease Control and Prevention supports access to cardiovascular care and provides funding for related health programs, creating a conducive environment for stent adoption. Such proactive measures not only facilitate early detection and management of cardiovascular diseases but also encourage the usage of innovative solutions like coronary stents, auguring well for the Coronary Stents Market Industry.
Coronary Stents Market Segment Insights
Coronary Stents Market Type Insights
The Coronary Stents Market is categorized into various Types, primarily comprising Drug-Eluting Stents, Bare-Metal Stents, and Bioabsorbable Stents, each holding a distinct share in the overall market.
In 2024, the Drug-Eluting Stents segment is projected to be valued at 3.6 USD Billion, indicating a dominant position in the market. This sub-segment is significant due to the advanced therapeutic benefits these stents provide, as they are designed to release a drug that inhibits tissue growth, thereby reducing the chances of re-narrowing in coronary arteries.
Following closely is the Bare-Metal Stents segment, valued at 2.14 USD Billion in 2024. This segment is essential for patients who may require a temporary solution without the complications associated with drug coatings, making it a viable option in scenarios where the use of medications is limited.
Lastly, the Bioabsorbable Stents segment, initially valued at 0.88 USD Billion in 2024, represents an innovative alternative in the market. These stents are designed to dissolve naturally in the body over time, providing temporary support to the vessel and reducing long-term complications associated with permanent implants.
The cumulative valuation of these segments not only highlights their importance in the Coronary Stents Market revenue but also reflects the diverse options available for patients and healthcare providers to address coronary artery diseases effectively.
The growth of these segments is driven by the increasing prevalence of cardiovascular diseases globally, advancements in stent technology, and the emphasis on improving patient outcomes, presenting significant opportunities for market players, while challenges include stringent regulatory approvals and varied patient responses to different types of stents.
The evolution of these segments captures a vital aspect of the ongoing efforts in the cardiovascular industry to innovate and push boundaries in treatment methodologies. Such advancements and the strategic focus on improving efficacy will potentially reshape the landscape of treatments, making the insights derived from the Coronary Stents Market data invaluable for stakeholders.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Coronary Stents Market Material Insights
The Coronary Stents Market, with an expected value of 6.62 billion USD in 2024, is experiencing notable growth driven by the increasing prevalence of cardiovascular diseases and the aging global population. The segmentation of the market by Material reveals distinct categories, including Metal Stents, Polymer Stents, and Coated Stents, each playing a critical role in the overall industry.
Metal Stents, often utilized for their strength and ease of deployment, hold a significant market share and are favored in various situations due to their proven long-term outcomes. Polymer Stents, which feature advanced materials, offer potential benefits in biocompatibility and flexibility, catering to patients with specific needs.
Coated Stents enhance performance by delivering medication to the affected area, thus reducing the risk of restenosis. Overall, the Coronary Stents Market is witnessing advancements in technology and materials, with growing investments in Research and Development that highlight opportunities for enhancing patient outcomes and addressing challenges related to stent failure and complications associated with their use.
The anticipated evolution in this sector will likely stem from ongoing innovation and the rising demand for more effective and safer stenting solutions globally.
Coronary Stents Market End Use Insights
The Coronary Stents Market showcases substantial growth within the End Use segment, primarily driven by the rising prevalence of cardiovascular diseases and the increasing adoption of minimally invasive procedures. By 2024, the market is expected to be valued at 6.62 USD Billion, reflecting a positive shift towards advanced healthcare provisions across the globe.
Hospitals remain a dominant force in the End Use segment, providing comprehensive cardiac care through specialized treatment options. Ambulatory Surgical Centers are gaining traction due to their efficiency and cost-effectiveness, catering to patients in need of outpatient surgeries.
Cardiac Catheterization Labs play a crucial role in the performance and success of stenting procedures, highlighting their significance within the healthcare landscape. The market is expected to reflect evolving trends, including technological advancements in stent design,
in addition to increasing patient awareness regarding cardiovascular health, which collectively drive the market growth. Despite these opportunities, the sector faces challenges such as regulatory hurdles and varying reimbursement scenarios across regions.
Nevertheless, the Coronary Stents Market revenue illustrates a robust pathway for expansion, with market growth driven by innovation and the need for effective treatment options on a global scale.
Coronary Stents Market Application Insights
The Coronary Stents Market is witnessing significant growth driven by the increasing prevalence of cardiovascular diseases, with a market valuation of 6.62 billion USD expected by 2024. Within the Application segment, conditions such as Coronary Artery Disease, Peripheral Artery Disease, and Acute Myocardial Infarction play pivotal roles.
Coronary Artery Disease is a leading cause of mortality globally and demands advanced treatment solutions like stenting to restore blood flow, making it a crucial area of focus in this market. Peripheral Artery Disease, often overlooked, can lead to severe complications, thereby creating a substantial opportunity for coronary stents to enhance patient outcomes.
Additionally, Acute Myocardial Infarction represents a dire medical emergency requiring prompt intervention, with stents providing essential support in restoring coronary artery patency. The trends in this market reflect a shift towards angioplasty and stenting techniques driven by technological advancements and improved patient management strategies.
With a projected steady increase in market growth over the coming years, the Application segment of the Coronary Stents Market is set to remain a critical component, addressing significant health challenges faced by the global population.
Coronary Stents Market Regional Insights
The Coronary Stents Market exhibits significant regional diversity, with North America leading the charge. In 2024, North America is expected to dominate with a valuation of 2.75 USD Billion, which is projected to grow to 3.63 USD Billion by 2035, reflecting its majority holding in the market due to advanced healthcare infrastructure and high demand for coronary interventions.
Europe follows closely, with a market value of 1.85 USD Billion in 2024, increasing to 2.47 USD Billion by 2035, driven by an aging population and rising prevalence of cardiovascular diseases. In the Asia Pacific region, the market is valued at 1.5 USD Billion in 2024 and is expected to reach 2.08 USD Billion by 2035.
This growth is fueled by increasing healthcare investments and improving access to medical technologies. South America, with a smaller market size of 0.4 USD Billion in 2024, will grow to 0.54 USD Billion by 2035, signifying a developing region with potential for future growth.
The Middle East and Africa represent the smallest share, with a market value of 0.12 USD Billion in 2024 and projected to increase to 0.18 USD Billion by 2035, challenging growth due to limited healthcare access in some areas. Collectively, these regions create a complex landscape for the Coronary Stents Market, influenced by varying economic, health, and social dynamics.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Coronary Stents Market Key Players and Competitive Insights
The Coronary Stents Market is characterized by a dynamic competitive landscape marked by innovation, strategic partnerships, and a diverse portfolio of products aimed at addressing the growing incidence of cardiovascular diseases.
As the prevalence of heart-related ailments rises globally, the demand for advanced coronary stents has surged, driving manufacturers to develop innovative and effective solutions. The market is influenced by factors such as technological advancements, regulatory approvals, and the ongoing quest for improved patient outcomes, which compel companies to engage in rigorous research and development.
Players in the market are also focusing on cost-effective solutions to meet the needs of healthcare providers and patients, enhancing competition and encouraging market growth.
Boston Scientific Corporation holds a prominent position in the Coronary Stents Market, leveraging its extensive experience and innovative product offerings. The company's strengths lie in its strong research and development capabilities, which allow for the continual introduction of advanced coronary stents that enhance procedural outcomes and minimize complications.
With a global operational footprint, Boston Scientific Corporation has a widespread market presence, supplying advanced solutions to diverse regions. The company’s commitment to innovation is reflected in its comprehensive product range, which includes both drug-eluting and bare-metal stents, catering to various hospital and outpatient settings.
Their focus on clinical evidence and partnerships with healthcare professionals further solidifies their leadership position in the market, making them a key player in the coronary stenting field.
Stentys is another noteworthy player in the Coronary Stents Market, primarily recognized for its innovative self-expanding stent technology designed to treat patients with acute myocardial infarction and other coronary conditions. The company emphasizes its commitment to providing effective solutions that improve patient outcomes and reduce complications associated with cardiovascular interventions.
Stentys has established a strategic market presence through collaborations and partnerships that enhance its distribution channels. The company's focus on research and development has led to a strong portfolio of products specifically tailored for various coronary conditions, further widening its market reach.
Stentys has also engaged in mergers and acquisitions to bolster its technological capabilities and expand its product offerings, positioning itself as a compelling alternative within the global landscape of coronary stenting solutions. Through these initiatives, Stentys aims to address the evolving challenges of healthcare providers and support the growing demand for innovative cardiovascular interventions.
Key Companies in the Coronary Stents Market Include
- Boston Scientific Corporation
- Stentys
- Q3 Medical Devices Limited
- Bayer AG
- Biosensors International Group
- Cook Medical
- Medtronic PLC
- Spectranetics
- Cardinal Health
- Avinger
- Terumo Corporation
- Johnson & Johnson
- Merit Medical Systems
- Abbott Laboratories
Coronary Stents Market Industry Developments
Recent developments in the Coronary Stents Market have shown significant activity and progress, particularly with companies like Boston Scientific Corporation, Abbott Laboratories, and Medtronic PLC. In September 2023, Abbott Laboratories announced the launch of an advanced drug-eluting stent, enhancing treatment efficiency for patients with coronary artery disease.
Furthermore, Medtronic PLC has made strides in expanding its product offerings to reflect the growing demand for innovative stenting solutions. Current affairs indicate a continuous evolution in market dynamics, with an increasing emphasis on collaboration among key players.
Notably, in June 2023, Boston Scientific Corporation completed the acquisition of device maker BVS Medical, enhancing its portfolio in the coronary intervention space. The global market valuation for coronary stents is experiencing substantial growth, projected to surpass USD 6 billion by 2025, driven by rising incidences of cardiovascular diseases.
Additionally, regulatory shifts and increasing investment in Research and Development are optimizing product performance and patient outcomes. Over the last two years, the market has seen a pronounced shift towards minimally invasive heart procedures, and in March 2022, Terumo Corporation launched a cutting-edge hybrid stent technology, representing a leap in coronary intervention techniques.
Coronary Stents Market Segmentation Insights
Coronary Stents Market Type Outlook
- Drug-Eluting Stents
- Bare-Metal Stents
- Bioabsorbable Stents
Coronary Stents Market Material Outlook
- Metal Stents
- Polymer Stents
- Coated Stents
Coronary Stents Market End Use Outlook
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Labs
Coronary Stents Market Application Outlook
- Coronary Artery Disease
- Peripheral Artery Disease
- Acute Myocardial Infarction
Coronary Stents Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
|
Report Attribute/Metric
|
Details
|
|
Market Size 2023
|
6.43(USD Billion)
|
|
Market Size 2024
|
6.62(USD Billion)
|
|
Market Size 2035
|
9.2(USD Billion)
|
|
Compound Annual Growth Rate (CAGR)
|
3.04% (2025 - 2035)
|
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
|
Base Year
|
2024
|
|
Market Forecast Period
|
2025 - 2035
|
|
Historical Data
|
2019 - 2024
|
|
Market Forecast Units
|
USD Billion
|
|
Key Companies Profiled
|
Boston Scientific Corporation, Stentys, Q3 Medical Devices Limited, Bayer AG, Biosensors International Group, Cook Medical, Medtronic PLC, Spectranetics, Cardinal Health, Avinger, Terumo Corporation, Johnson & Johnson, Merit Medical Systems, Abbott Laboratories
|
|
Segments Covered
|
Type, Material, End Use, Application, Regional
|
|
Key Market Opportunities
|
Emerging markets expansion, Technological advancements in stent design, Increased aging population, Rising prevalence of cardiovascular diseases, Growth in minimally invasive procedures.
|
|
Key Market Dynamics
|
rising prevalence of cardiovascular diseases, technological advancements in stent design, increasing preference for minimally invasive procedures, growing geriatric population, expanding healthcare infrastructure in emerging markets
|
|
Countries Covered
|
North America, Europe, APAC, South America, MEA
|
Coronary Stents Market Highlights:
Frequently Asked Questions (FAQ) :
The Coronary Stents Market was valued at 6.62 USD Billion in 2024.
By 2035, the Coronary Stents Market is projected to reach a value of 9.2 USD Billion.
The expected compound annual growth rate for the market from 2025 to 2035 is 3.04%.
North America holds the largest market share, valued at 2.75 USD Billion in 2024.
The Asia Pacific region is expected to grow to 2.08 USD Billion by 2035, up from 1.5 USD Billion in 2024.
The market value for Drug-Eluting Stents is 3.6 USD Billion in 2024 and is expected to rise to 4.6 USD Billion by 2035.
Major players include Boston Scientific Corporation, Medtronic PLC, and Abbott Laboratories, among others.
The expected market value for Bare-Metal Stents by 2035 is 2.9 USD Billion.
Challenges may include regulatory hurdles and competition among established and emerging players.
The Bioabsorbable Stents segment is anticipated to show significant growth, expected to reach 1.7 USD Billion by 2035.
